Showing results (331-340 of 380) with videos related to

Sort By:
Pageof 38
Clinical Trials (London, England)|March 19, 2019
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials programJay S Shavadia, Abhinav Sharma, Xiangqiong Gu, et al.
Diabetes Care|April 28, 2004
Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trialPhilip Home, Paul Bartley, David Russell-Jones, et al.
Lancet (London, England)|June 9, 2009
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trialPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2020
Atypical protein kinase C iota (PKCλ/ι) ensures mammalian development by establishing the maternal-fetal exchange interfaceBhaswati Bhattacharya, Pratik Home, Avishek Ganguly, et al.
European Heart Journal|February 2, 2010
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trialMichel Komajda, John J V McMurray, Henning Beck-Nielsen, et al.
Diabetes Research and Clinical Practice|April 1, 2015
Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continentsPhilip D Home, Marie-Paule Dain, Nick Freemantle, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2020
TEAD4 ensures postimplantation development by promoting trophoblast self-renewal: An implication in early human pregnancy lossBiswarup Saha, Avishek Ganguly, Pratik Home, et al.
Scientific Reports|February 22, 2018
Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney DiseaseJessica Idowu, Trisha Home, Nisha Patel, et al.
Diabetes Care|May 24, 2014
Insulin therapy in people with type 2 diabetes: opportunities and challenges?Philip Home, Matthew Riddle, William T Cefalu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 24, 2006
Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetesS G Ashwell, S A Amiel, R W Bilous, et al.
Pageof 38